LAS VEGAS, June 28, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative life-saving drugs, announced today its Board of Directors has unanimously decided to reorganize its stock structure by initiating a one-for-six reverse split of its common stock which shall become effective at the opening of trading on July 5, 2007 in order, to comply with The American Stock Exchange’s Company Guide, Sections 1003(f)(v), regarding listing requirements for a Company’s stock selling at a low price per share for a substantial period of time.
